Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:48 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4CompletedINTERVENTIONAL

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

ClinicalTrials.gov · NCT04897802 · Registry updated: 2026-01-20

Condition / research focus: Hypopituitarism; Central Diabetes Insipidus; Panhypopituitarism; Psychological Disorder; Social Isolation; Hypothalamic Diseases; Pituitary Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2021-09-13. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Experimental: GLP1-RA (exenatide) administration (drug) — also listed as: exenatide administration
Control: Placebo administration (drug) — also listed as: placebo administration (sodium chloride)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU

ClinicalTrials.gov · NCT07351799 · Registry updated: 2026-01-20

Condition / research focus: Lactation; Mindfulness; NICU; Breastmilk; Neonatal; Meditation; Pumping, Breast; Cortisol; Oxytocin; Anxiety; Depression
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2025-09-22. Completion: 2026-11-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Standard of Care (behavioral)
Mindfulness-based Intervention (behavioral)

Where the study takes place — 1 listed sites

Mayo Clinic in Rochester
Rochester, Minnesota, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableEnrolling by invitationOBSERVATIONAL

Salivary Oxytocin as a Biomarker of Psychedelic Treatment

ClinicalTrials.gov · NCT07345858 · Registry updated: 2026-01-16

Condition / research focus: Major Depressive Disorder (MDD)
Sponsor: University of Geneva, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2026-01-05. Completion: 2026-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Geneva University Hospitals
Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

ClinicalTrials.gov · NCT04218409 · Registry updated: 2026-01-14

Condition / research focus: Pain
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2021-09-02. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OxyCODONE 5 mg Oral Tablet (drug)
Oxytocin nasal spray (drug)
Placebo Oxycodone (other)
Placebo oxytocin (other)
OxyCODONE 2.5 mg Oral Tablet (drug)

Where the study takes place — 1 listed sites

University of Florida
Gainesville, Florida, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour

ClinicalTrials.gov · NCT07321379 · Registry updated: 2026-01-12

Condition / research focus: Prolonged Labor; Labor Dystocia
Sponsor: Copenhagen University Hospital, Hvidovre
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-02-01. Completion: 2028-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sodium bicarbonate (drug)
Placebo (drug)

Where the study takes place — 3 listed sites

Aarhus University Hospital
Aarhus, Denmark
Site recruitment: Not reported
Copenhagen University Hospital, Hvidovre
Copenhagen, Denmark
Site recruitment: Not reported
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn

ClinicalTrials.gov · NCT06651476 · Registry updated: 2026-01-12

Condition / research focus: Sunburn
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2024-12-05. Completion: 2025-11-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

ClinicalTrials.gov · NCT05782816 · Registry updated: 2026-01-09

Condition / research focus: Labor Long
Sponsor: The University of Texas Medical Branch, Galveston
Countries with listed sites: United States
Registry dates and results: Start: 2023-04-17. Completion: 2025-06-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (Low dose) (drug) — also listed as: Pitocin, Syntocinon
Oxytocin (High dose) (drug) — also listed as: Pitocin, Syntocinon

Where the study takes place — 1 listed sites

University of Texas Medical Branch
Galveston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

ClinicalTrials.gov · NCT07318467 · Registry updated: 2026-01-06

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative (drug)
Intravenous Carbetocin alone (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter

ClinicalTrials.gov · NCT07237880 · Registry updated: 2026-01-06

Condition / research focus: Labor, Induced
Sponsor: Hillel Yaffe Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2025-04-22. Completion: 2027-04-22 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Papaverine 80 mg IV (drug)
Placebo (Normal Saline) (drug)

Where the study takes place — 1 listed sites

Hillel Yaffe Medical Center
Hadera, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Role of Oxytocin in the Second Stage of Labor

ClinicalTrials.gov · NCT04303702 · Registry updated: 2026-01-05

Condition / research focus: Labor Complication
Sponsor: Washington University School of Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2022-07-01. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Continue Oxytocin (drug)
Discontinue Oxytocin (other)

Where the study takes place — 1 listed sites

Barnes Jewish Hospital
St Louis, Missouri, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour

ClinicalTrials.gov · NCT04760496 · Registry updated: 2025-12-26

Condition / research focus: Obese; Primiparous Women; Oxytocin
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2021-10-02. Completion: 2025-01-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin 4 mIU/mL (drug)
Oxytocin 2 mIU/mL (drug)

Where the study takes place — 12 listed sites

CHU d'Angers
Angers, France
Site recruitment: Not reported
CHU de Bordeaux (Pellegrin)
Bordeaux, France
Site recruitment: Not reported
Hôpital Béclère
Clamart, France
Site recruitment: Not reported
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
CHU de Montpellier
Montpellier, France
Site recruitment: Not reported
CHU de Nimes
Nîmes, France
Site recruitment: Not reported
Hôpital Cochin Port Royal
Paris, France
Site recruitment: Not reported
Hôpital Tenon
Paris, France
Site recruitment: Not reported
CHU de Poissy St Germain
Poissy, France
Site recruitment: Not reported
CHU de Saint Etienne
Saint-Etienne, France
Site recruitment: Not reported
CHU de Strasbourg (Centre Médico Chirurgical et Obstétrical)
Schiltigheim, France
Site recruitment: Not reported
CHU de Strasbourg (Hôpital de Hautepierre)
Strasbourg, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Observational Study

ClinicalTrials.gov · NCT07299708 · Registry updated: 2025-12-23

Condition / research focus: Labor Progression; Pregnancy
Sponsor: Tepecik Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-08-10. Completion: 2025-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

No Intervention: Observational Cohort (other)

Where the study takes place — 1 listed sites

Tepecik Training and Research Hospital
Izmir, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome

ClinicalTrials.gov · NCT02804373 · Registry updated: 2025-12-05

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2014-06. Completion: 2019-06-18 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (OXT) continuous (drug) — also listed as: Syntocinon
Placebo (drug)
Placebo continuous (drug)
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Centre de référence Prader-Willi - Hôpital Purpan
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia

ClinicalTrials.gov · NCT06136390 · Registry updated: 2025-12-01

Condition / research focus: Schizophrenia Spectrum Disorders
Sponsor: Charite University, Berlin, Germany
Countries with listed sites: Germany
Registry dates and results: Start: 2023-09-30. Completion: 2024-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (other)
Placebo (other)

Where the study takes place — 1 listed sites

Charité Universitätsmedizin Berlin, Campus Benjamin Franklin
Berlin, State of Berlin, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter

ClinicalTrials.gov · NCT06803992 · Registry updated: 2025-12-01

Condition / research focus: Induction of Labor
Sponsor: HaEmek Medical Center, Israel
Countries with listed sites: Israel
Registry dates and results: Start: 2025-04-06. Completion: 2027-01-29 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dinoprostone vaginal insert (drug) — also listed as: Propess
Dinoprostone gel and Foley catheter balloon (combination_product)

Where the study takes place — 1 listed sites

Emek medical center
Afula, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Methods of Labor Induction and Perinatal Outcomes

ClinicalTrials.gov · NCT02477085 · Registry updated: 2025-11-20

Condition / research focus: Induction of Labor
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2015-11. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

all women with an induced labor (other)

Where the study takes place — 1 listed sites

Port-Royal maternity unit, Cochin Hospital, Assistance publique des Hôpitaux de Paris (APHP
Paris, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Sleep Disorders in Hypothalamic and Pituitary Damage

ClinicalTrials.gov · NCT07143266 · Registry updated: 2025-11-18

Condition / research focus: Hypopituitarism; Sleep Wake Disorders; Hypothalamic Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2025-09-01. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

This is an observational study. No drugs will be administered (other)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial (EAGER Pilot Trial)

ClinicalTrials.gov · NCT06641141 · Registry updated: 2025-11-18

Condition / research focus: Gestational Diabetes Mellitus (GDM)
Sponsor: Ottawa Hospital Research Institute
Countries with listed sites: Canada
Registry dates and results: Start: 2025-04-07. Completion: 2028-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Induction of Labour (procedure) — also listed as: IOL, Induction

Where the study takes place — 1 listed sites

The Ottawa Hospital
Ottawa, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Potential Benefits of the Somatic Psychoeducational Intervention

ClinicalTrials.gov · NCT05766852 · Registry updated: 2025-11-10

Condition / research focus: Work Related Stress
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2023-10-23. Completion: 2024-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Somatic Psychoeducational Intervention (behavioral)

Where the study takes place — 1 listed sites

UF Health Jacksonville
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin

ClinicalTrials.gov · NCT05929339 · Registry updated: 2025-10-28

Condition / research focus: Acute Pain; Chronic Pain; Healthy Volunteer
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2023-08-17. Completion: 2024-10-02 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:48 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 4CompletedINTERVENTIONAL

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

ClinicalTrials.gov · NCT04897802 · Registry updated: 2026-01-20

Condition / research focus: Hypopituitarism; Central Diabetes Insipidus; Panhypopituitarism; Psychological Disorder; Social Isolation; Hypothalamic Diseases; Pituitary Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2021-09-13. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Experimental: GLP1-RA (exenatide) administration (drug) — also listed as: exenatide administration
Control: Placebo administration (drug) — also listed as: placebo administration (sodium chloride)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU

ClinicalTrials.gov · NCT07351799 · Registry updated: 2026-01-20

Condition / research focus: Lactation; Mindfulness; NICU; Breastmilk; Neonatal; Meditation; Pumping, Breast; Cortisol; Oxytocin; Anxiety; Depression
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2025-09-22. Completion: 2026-11-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Standard of Care (behavioral)
Mindfulness-based Intervention (behavioral)

Where the study takes place — 1 listed sites

Mayo Clinic in Rochester
Rochester, Minnesota, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableEnrolling by invitationOBSERVATIONAL

Salivary Oxytocin as a Biomarker of Psychedelic Treatment

ClinicalTrials.gov · NCT07345858 · Registry updated: 2026-01-16

Condition / research focus: Major Depressive Disorder (MDD)
Sponsor: University of Geneva, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2026-01-05. Completion: 2026-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Geneva University Hospitals
Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

ClinicalTrials.gov · NCT04218409 · Registry updated: 2026-01-14

Condition / research focus: Pain
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2021-09-02. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OxyCODONE 5 mg Oral Tablet (drug)
Oxytocin nasal spray (drug)
Placebo Oxycodone (other)
Placebo oxytocin (other)
OxyCODONE 2.5 mg Oral Tablet (drug)

Where the study takes place — 1 listed sites

University of Florida
Gainesville, Florida, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour

ClinicalTrials.gov · NCT07321379 · Registry updated: 2026-01-12

Condition / research focus: Prolonged Labor; Labor Dystocia
Sponsor: Copenhagen University Hospital, Hvidovre
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-02-01. Completion: 2028-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sodium bicarbonate (drug)
Placebo (drug)

Where the study takes place — 3 listed sites

Aarhus University Hospital
Aarhus, Denmark
Site recruitment: Not reported
Copenhagen University Hospital, Hvidovre
Copenhagen, Denmark
Site recruitment: Not reported
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn

ClinicalTrials.gov · NCT06651476 · Registry updated: 2026-01-12

Condition / research focus: Sunburn
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2024-12-05. Completion: 2025-11-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Atrium Health Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

ClinicalTrials.gov · NCT05782816 · Registry updated: 2026-01-09

Condition / research focus: Labor Long
Sponsor: The University of Texas Medical Branch, Galveston
Countries with listed sites: United States
Registry dates and results: Start: 2023-04-17. Completion: 2025-06-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (Low dose) (drug) — also listed as: Pitocin, Syntocinon
Oxytocin (High dose) (drug) — also listed as: Pitocin, Syntocinon

Where the study takes place — 1 listed sites

University of Texas Medical Branch
Galveston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

ClinicalTrials.gov · NCT07318467 · Registry updated: 2026-01-06

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative (drug)
Intravenous Carbetocin alone (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter

ClinicalTrials.gov · NCT07237880 · Registry updated: 2026-01-06

Condition / research focus: Labor, Induced
Sponsor: Hillel Yaffe Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2025-04-22. Completion: 2027-04-22 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Papaverine 80 mg IV (drug)
Placebo (Normal Saline) (drug)

Where the study takes place — 1 listed sites

Hillel Yaffe Medical Center
Hadera, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Role of Oxytocin in the Second Stage of Labor

ClinicalTrials.gov · NCT04303702 · Registry updated: 2026-01-05

Condition / research focus: Labor Complication
Sponsor: Washington University School of Medicine
Countries with listed sites: United States
Registry dates and results: Start: 2022-07-01. Completion: 2027-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Continue Oxytocin (drug)
Discontinue Oxytocin (other)

Where the study takes place — 1 listed sites

Barnes Jewish Hospital
St Louis, Missouri, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Increased Oxytocin Doses on the Mode of Delivery in Obese Primiparous Women With Spontaneous or Induced Labour

ClinicalTrials.gov · NCT04760496 · Registry updated: 2025-12-26

Condition / research focus: Obese; Primiparous Women; Oxytocin
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2021-10-02. Completion: 2025-01-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin 4 mIU/mL (drug)
Oxytocin 2 mIU/mL (drug)

Where the study takes place — 12 listed sites

CHU d'Angers
Angers, France
Site recruitment: Not reported
CHU de Bordeaux (Pellegrin)
Bordeaux, France
Site recruitment: Not reported
Hôpital Béclère
Clamart, France
Site recruitment: Not reported
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Site recruitment: Not reported
CHU de Montpellier
Montpellier, France
Site recruitment: Not reported
CHU de Nimes
Nîmes, France
Site recruitment: Not reported
Hôpital Cochin Port Royal
Paris, France
Site recruitment: Not reported
Hôpital Tenon
Paris, France
Site recruitment: Not reported
CHU de Poissy St Germain
Poissy, France
Site recruitment: Not reported
CHU de Saint Etienne
Saint-Etienne, France
Site recruitment: Not reported
CHU de Strasbourg (Centre Médico Chirurgical et Obstétrical)
Schiltigheim, France
Site recruitment: Not reported
CHU de Strasbourg (Hôpital de Hautepierre)
Strasbourg, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Observational Study

ClinicalTrials.gov · NCT07299708 · Registry updated: 2025-12-23

Condition / research focus: Labor Progression; Pregnancy
Sponsor: Tepecik Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-08-10. Completion: 2025-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

No Intervention: Observational Cohort (other)

Where the study takes place — 1 listed sites

Tepecik Training and Research Hospital
Izmir, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome

ClinicalTrials.gov · NCT02804373 · Registry updated: 2025-12-05

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2014-06. Completion: 2019-06-18 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (OXT) continuous (drug) — also listed as: Syntocinon
Placebo (drug)
Placebo continuous (drug)
Oxytocin (drug) — also listed as: Syntocinon

Where the study takes place — 1 listed sites

Centre de référence Prader-Willi - Hôpital Purpan
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia

ClinicalTrials.gov · NCT06136390 · Registry updated: 2025-12-01

Condition / research focus: Schizophrenia Spectrum Disorders
Sponsor: Charite University, Berlin, Germany
Countries with listed sites: Germany
Registry dates and results: Start: 2023-09-30. Completion: 2024-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (other)
Placebo (other)

Where the study takes place — 1 listed sites

Charité Universitätsmedizin Berlin, Campus Benjamin Franklin
Berlin, State of Berlin, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter

ClinicalTrials.gov · NCT06803992 · Registry updated: 2025-12-01

Condition / research focus: Induction of Labor
Sponsor: HaEmek Medical Center, Israel
Countries with listed sites: Israel
Registry dates and results: Start: 2025-04-06. Completion: 2027-01-29 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dinoprostone vaginal insert (drug) — also listed as: Propess
Dinoprostone gel and Foley catheter balloon (combination_product)

Where the study takes place — 1 listed sites

Emek medical center
Afula, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Methods of Labor Induction and Perinatal Outcomes

ClinicalTrials.gov · NCT02477085 · Registry updated: 2025-11-20

Condition / research focus: Induction of Labor
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2015-11. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

all women with an induced labor (other)

Where the study takes place — 1 listed sites

Port-Royal maternity unit, Cochin Hospital, Assistance publique des Hôpitaux de Paris (APHP
Paris, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Sleep Disorders in Hypothalamic and Pituitary Damage

ClinicalTrials.gov · NCT07143266 · Registry updated: 2025-11-18

Condition / research focus: Hypopituitarism; Sleep Wake Disorders; Hypothalamic Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2025-09-01. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

This is an observational study. No drugs will be administered (other)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Feasibility Of Expectant Management Versus Induction At 38 Weeks Among Individuals With Gestational Diabetes Mellitus: A Randomized Controlled Pilot Trial (EAGER Pilot Trial)

ClinicalTrials.gov · NCT06641141 · Registry updated: 2025-11-18

Condition / research focus: Gestational Diabetes Mellitus (GDM)
Sponsor: Ottawa Hospital Research Institute
Countries with listed sites: Canada
Registry dates and results: Start: 2025-04-07. Completion: 2028-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Induction of Labour (procedure) — also listed as: IOL, Induction

Where the study takes place — 1 listed sites

The Ottawa Hospital
Ottawa, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Potential Benefits of the Somatic Psychoeducational Intervention

ClinicalTrials.gov · NCT05766852 · Registry updated: 2025-11-10

Condition / research focus: Work Related Stress
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2023-10-23. Completion: 2024-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Somatic Psychoeducational Intervention (behavioral)

Where the study takes place — 1 listed sites

UF Health Jacksonville
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin

ClinicalTrials.gov · NCT05929339 · Registry updated: 2025-10-28

Condition / research focus: Acute Pain; Chronic Pain; Healthy Volunteer
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2023-08-17. Completion: 2024-10-02 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →